Back
Nova Mentis Life Science 10K Form
Sell
13
NOVA.CX
Nova Mentis Life Science
Last Price:
0.0100
Seasonality Move:
31.15%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive NOVA.CX News And Ratings
See the #1 stock for the next 7 days that we like better than NOVA.CX
NOVA.CX Financial Statistics
Sales & Book Value
Annual Sales: | $11.47K |
---|---|
Cash Flow: | $-9.8K |
Price / Cash Flow: | 0 |
Annual Sales: | $-0.01 |
Price / Book: | 0 |
Profitability
EPS (TTM): | -0.00490 |
---|---|
Net Income (TTM): | $-721.8K |
Gross Margin: | $0 |
Return on Equity: | 0% |
Return on Assets: | 0% |
Nova Mentis Life Science Earnings Forecast
Key Nova Mentis Life Science Financial Ratios
- The Selling, General & Administrative Expenses for NOVA.CX have been equal to 13,175.07% of Gross Profit Margin.
- The Interest Expense is 0.00% of Operating Income.
- Per Share Earnings over the last 18 years have been positive in 7 years.
Nova Mentis Life Science Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | CNSX |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | NOVA.CX |
Website: | novamentis.ca |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 0 |
Quick Ratio: | 0 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
NOVA.CX Technical Analysis vs Fundamental Analysis
Sell
13
Nova Mentis Life Science (NOVA.CX)
is a Sell
Is Nova Mentis Life Science a Buy or a Sell?
-
Nova Mentis Life Science stock is rated a Sell
The current Nova Mentis Life Science [NOVA.CX] share price is $0.0050. The Score for NOVA.CX is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.